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Background: The possible association between a decrease in platelet count (DPC) and clinical outcome in patients treated with transcatheter 
aortic valve replacement (TAVR) is unknown.
Methods: The analysis included 143 consecutive patients undergoing TAVR of Edwards SAPIEN valves (78.4% using transfemoral access and 21.4% 
transapical) and included a prospective registry. Intravenous heparin was used during these procedures. Rates of thrombocytopenia (platelet count 
<150,000/microliter) were examined. According to the magnitude of the DPC, the population was divided into three groups: no/mild DPC (<25%), 
moderate DPC (≥25 and <50%), and severe DPC (≥50%).
Results: Before TAVR, 25 patients (17.5%) had thrombocytopenia versus 114 patients after the procedure (76%, p <0.001). The rate of moderate/
severe DPC post procedure was 83.2%. (Table) Although the group with no/mild DPC was younger than the groups with moderate/severe DPC, there 
was no significant difference in calculated risk scores between these groups. The degree of DPC was associated with major vascular complication 
rate. In-hospital death rate was higher in the group with severe DPC than in the other groups.
Conclusion: Most patients undergoing TAVR have thrombocytopenia after the procedure. DPC is associated with major vascular complications and 
severe DPC is associated with high in-hospital death rates. 
No/minimal DPC (<25%)
n=24
Moderate DPC (≥25 and <50%)
n=67
Severe DPC (≥50%)
n=52
P
Age (years) 82.5 ± 6.6 84.9 ± 5.6 85.5 ± 4.9 0.04
STS score (%) 12.3 ± 4.7 11.4 ± 3.1 12.4 ± 3.6 0.32
Logistic EuroSCORE 42.0 ± 22.4 44.1 ± 20.9 41.7 ± 21.2 0.64
Major vascular complication (%) 0 11.4 35.3 <0.001
30-days stroke (%) 0 7.5 3.8 0.11
In-hospital death (%) 7.1 2.2 23.5 <0.001
